● Recruiting

Study of A Venetoclax-based, Anthracycline-free Regimen in Newly Diagnosed CBFβ::MYH11(+) AML

Condition: Acute Myeloid Leukemia · Sponsor: The First Affiliated Hospital of Soochow University

PhasePhase 2

Planned participants40

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

This investigator-initiated, single-arm, phase II trial is aimed to evaluate the efficacy and safety of a venetoclax-based, anthracycline-free regimen in patients with newly diagnosed CBFβ::MYH11-positive acute myeloid leukemia.

This description comes directly from the study's public registry record.

Talk to the study team

Ying Wang · 008613656214782 · wangying77@suda.edu.cn

Always discuss trial participation with your own doctor first.

Locations (2)

Ethical Committee of the First Affiliated Hospital of Soochow University	Suzhou, Jiangsu, China	Recruiting
The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology	Suzhou, Jiangsu, China	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06429098